X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Wockhardt with Panacea Biotech - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT LTD. vs PANACEA BIOTECH - Comparison Results

WOCKHARDT LTD.    Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT LTD. PANACEA BIOTECH WOCKHARDT LTD./
PANACEA BIOTECH
 
P/E (TTM) x 16.1 80.7 20.0% View Chart
P/BV x 1.6 1.8 91.8% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 WOCKHARDT LTD.   PANACEA BIOTECH
EQUITY SHARE DATA
    WOCKHARDT LTD.
Mar-16
PANACEA BIOTECH
Mar-14
WOCKHARDT LTD./
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs2,000149 1,345.0%   
Low Rs70682 857.6%   
Sales per share (Unadj.) Rs403.784.1 479.8%  
Earnings per share (Unadj.) Rs29.5-18.3 -161.0%  
Cash flow per share (Unadj.) Rs42.4-6.7 -632.5%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs323.483.7 386.3%  
Shares outstanding (eoy) m110.5161.25 180.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.41.4 244.1%   
Avg P/E ratio x45.9-6.3 -727.7%  
P/CF ratio (eoy) x31.9-17.2 -185.2%  
Price / Book Value ratio x4.21.4 303.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m149,5097,074 2,113.4%   
No. of employees `0007.42.8 268.2%   
Total wages/salary Rs m9,4431,449 651.6%   
Avg. sales/employee Rs Th6,048.61,874.1 322.8%   
Avg. wages/employee Rs Th1,280.2527.0 242.9%   
Avg. net profit/employee Rs Th441.5-407.7 -108.3%   
INCOME DATA
Net Sales Rs m44,6145,154 865.7%  
Other income Rs m970100 971.4%   
Total revenues Rs m45,5845,254 867.7%   
Gross profit Rs m5,038-766 -657.5%  
Depreciation Rs m1,426711 200.5%   
Interest Rs m1,0121,503 67.3%   
Profit before tax Rs m3,570-2,881 -123.9%   
Minority Interest Rs m-6511 -602.8%   
Prior Period Items Rs m6-6 -112.3%   
Extraordinary Inc (Exp) Rs m01,771 0.0%   
Tax Rs m25517 1,516.7%   
Profit after tax Rs m3,257-1,121 -290.4%  
Gross profit margin %11.3-14.9 -76.0%  
Effective tax rate %7.1-0.6 -1,223.7%   
Net profit margin %7.3-21.8 -33.5%  
BALANCE SHEET DATA
Current assets Rs m39,9063,810 1,047.3%   
Current liabilities Rs m18,4238,365 220.2%   
Net working cap to sales %48.2-88.4 -54.5%  
Current ratio x2.20.5 475.6%  
Inventory Days Days90156 57.9%  
Debtors Days Days9867 146.1%  
Net fixed assets Rs m35,83214,480 247.5%   
Share capital Rs m55361 901.3%   
"Free" reserves Rs m30,370903 3,362.9%   
Net worth Rs m35,7395,127 697.0%   
Long term debt Rs m16,5425,832 283.6%   
Total assets Rs m79,52219,433 409.2%  
Interest coverage x4.5-0.9 -494.0%   
Debt to equity ratio x0.51.1 40.7%  
Sales to assets ratio x0.60.3 211.6%   
Return on assets %5.42.0 273.3%  
Return on equity %9.1-21.9 -41.7%  
Return on capital %8.73.6 237.9%  
Exports to sales %11.624.5 47.3%   
Imports to sales %4.510.2 43.8%   
Exports (fob) Rs m5,1771,264 409.6%   
Imports (cif) Rs m1,990525 379.2%   
Fx inflow Rs m7,5891,539 493.0%   
Fx outflow Rs m2,878942 305.6%   
Net fx Rs m4,711597 788.8%   
CASH FLOW
From Operations Rs m716599 119.5%  
From Investments Rs m-8,182-438 1,868.4%  
From Financial Activity Rs m2,543-303 -840.3%  
Net Cashflow Rs m-4,923-141 3,484.2%  

Share Holding

Indian Promoters % 74.5 74.5 100.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.3 0.6 383.3%  
FIIs % 7.7 1.3 592.3%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 23.6 65.3%  
Shareholders   67,757 10,259 660.5%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT LTD. With:   AUROBINDO PHARMA  MERCK LTD  NOVARTIS  FULFORD INDIA  ORCHID PHARMA LTD  

Compare WOCKHARDT LTD. With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Red; Auto Stocks Witness Selling(01:30 pm)

After opening the day flat, share markets in India continued to witness selling pressure and are currently trading in red. Sectoral indices are trading on a mixed note with stocks in the metals sector.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT LTD. SHARE PRICE


Aug 21, 2017 03:37 PM

TRACK WOCKHARDT LTD.

  • Track your investment in WOCKHARDT LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT LTD.

WOCKHARDT LTD. - VENUS REMEDIES COMPARISON

COMPARE WOCKHARDT LTD. WITH

MARKET STATS